Our portfolio

Rosetta invests in companies that have the potential to transform medical care.

Our focus is on companies at late-preclinical or clinical stages of development that are developing innovative therapeutics, medical devices or diagnostics.
We manage a series of venture funds, primarily with a secondary investment focus, and currently are actively managing our funds IV and V. Our portfolio companies are located across Europe, North America and Asia.

A selection of our portfolio of companies is shown below.

Find out more

Our people

We are headquartered in the UK and our team is located across Europe and Asia, providing us with broad geographic networks that have proven useful to support our portfolio companies.

About us

We are a specialist UK-based life science venture capital firm that invests globally to build leading healthcare companies and breakthrough technologies that can deliver benefits to human lives.